Brazil drug agency questions ‘transparency’ of China vaccine
340
BRASÍLIA, Dec 15, 2020 (BSS/AFP) – The Brazilian health regulator Anvisa on Monday accused China of using criteria that “are not transparent” to win emergency approval of its coronavirus vaccine CoronaVac, which is in the final phase of trials in Brazil.
“The Chinese criteria applied to grant the authorization of emergency use in China are not transparent,” Anvisa said in a statement.
The regulator, which sent a group of technicians to inspect the Sinovac plant in Beijing in early December, also warned against the “influence of issues related to geopolitics” in promoting vaccines.
Brazilian drug agency questions Chinese vaccine s transparency freemalaysiatoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freemalaysiatoday.com Daily Mail and Mail on Sunday newspapers.
Brazil drug agency questions transparency of China vaccine
3
published : 15 Dec 2020 at 11:45
3 The coronavirus pandemic has claimed more than 181,000 lives and infected almost 7 million people in Brazil (cemetery in Manaus, Brazil, pictured in June 2020).
BRASíLIA: The Brazilian health regulator Anvisa on Monday accused China of using criteria that are not transparent to win emergency approval of its coronavirus vaccine CoronaVac, which is in the final phase of trials in Brazil. The Chinese criteria applied to grant the authorisation of emergency use in China are not transparent, Anvisa said in a statement.
The regulator, which sent a group of technicians to inspect the Sinovac plant in Beijing in early December, also warned against the influence of issues related to geopolitics in promoting vaccines.
US, EU Push Forward Vaccine Approval As Fears Of Xmas Infections Grow ibtimes.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ibtimes.com.au Daily Mail and Mail on Sunday newspapers.
Brazil drug agency questions transparency of China COVID-19 vaccine
CoronaVac, produced by the Chinese private laboratory Sinovac in collaboration with the Butantan Institute of Sao Paulo, has been the subject of heated political debate in Brazil.
Share Via Email
| A+A A-
An employee of SinoVac works in a lab at a factory producing its SARS CoV-2 Vaccine for COVID-19 named CoronaVac in Beijing. (Photo | AP) By AFP
BRASILIA: Brazil s health regulator on Monday accused China of not being transparent in efforts to win emergency approval for its Covid-19 vaccine CoronaVac, currently in the final phase of trials in the hard-hit country.